ロード中...
Multikinase Inhibitor Treatment in Thyroid Cancer
Thyroid cancer is the most common endocrine malignancy. Most thyroid cancer types respond well to conventional treatment consisting of surgery and radioactive iodine (RAI) therapy. Unfortunately, some thyroid cancer types are resistant to surgical and RAI therapy. Multikinase inhibitors (MKIs) can b...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982227/ https://ncbi.nlm.nih.gov/pubmed/31861373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21010010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|